APC-Labeled Human HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Tetramer Protein
Produktgrößen
25 tests
£642,00
HL1-HA2H8-25TESTS
200 tests
£3833,00
HL1-HA2H8-200TESTS
Über dieses Produkt
- SKU:
- HL1-HA2H8
- Buffer:
- 0.2% BSA
- Konjugat:
- APC
- Weitere Details:
- NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A2 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients. The Human HLA-A*0201 NY-ESO-1 (SLLMWITQV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and SLLMWITQV peptide of the NY-ESO-1.
- Immunogen:
- HLA-A*0201 & B2M & NY-ESO-1 (SLLMWITQV)
- Molekulargewicht:
- 36.3 kDa and 13.8 kDa
- Physischer Zustand:
- Powder
- Versandbedingungen:
- Ambient
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- ACRO Biosystems
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
